A Comparative Study to Assess the Mental Health Problems,Quality of Life,Work Ability and Social Adjustments Among OST and Non-OST Drug Users in Chandigarh

Abstract

Introduction:

Injectable drug use is a cause of disease burden and a contributor to blood-borne virus transmission and health-related problems. It is one of the serious problems of our country. The best suitable strategy of treatment for opioid dependence is ‘opioid substitution therapy’ (OST). It is beneficial for the injectable drug users (IDUs) in reduction in the behaviour of injecting and opioid use, which helps in reducing criminal activities, domestic violence, enhancing ties within the family and improving productivity.

Objective:

To assess the mental health problems, quality of life, work ability and social adjustability among OST and non-OST IDUs.

Materials and Methods:

The descriptive study was conducted among 100 male IDUs (50 in the OST group and 50 in the non-OST group), registered with the two selected non-governmental organizations (NGOs) of Chandigarh selected by using the consecutive sampling technique. The OST group was contacted during their visit to the centre for receiving the daily dose of OST, while the non-OST group was contacted during their visit to the NGO centres for getting fresh syringes in exchange with used syringes under the syringe exchange programme. The data were collected by interviewing the study subjects by using the interview schedule comprising of the (a) socio-demographic profile, (b) health problems, (c) substance-use-related problems scale, (d) work ability and social adjustability scale, (e) the depression, anxiety and stress scale-21 and (f) World Health Organization Quality-of-Life BREF (WHOQOL BREF) Scale. All the tools were standardized and available in the open domain.

Results:

The study subjects were in the age group of 18–58 years with the mean age of 27.52 ± 6.67 years. Significantly lesser problems in the OST group study participants related to health, occupation, finance, legal, family, marital and social status were reported than those in the non-OST group participants (t-test, p < 0.01). A significantly higher percentage of the study participants in the non-OST group had depression, anxiety and stress than that in the OST group. Quality of life of IDUs in the OST group was significantly better than that of IDUs in the non-OST group, as per the WHOQOL BREF Scale (Mann–Whitney U test, p < 0.05).

Conclusion:

IDUs on OST therapy (OST group) were having lesser problems in the area of health (physical and mental), occupational, financial, legal, family, marital, social and better quality of life than those in the non-OST group.

Keywords

IDU OST non-OST quality of life

Get full access to this article

View all access options for this article.

References

World Health Organization, International Narcotics Control Board, United Nations Office on Drugs and Crime, editors. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence . Geneva: World Health Organization, https://www.who.int/substance_abuse/publications/Opioid_dependence_guidelines.pdf (2009, accessed 24 January 2019).

United Nations Office on Drugs and Crime. National survey on extent, pattern and trends of drug abuse in India . New Delhi: Ministry of Social Justice and Empowerment, Government of India, and United Nations Office on Drugs and Crime, https://www.unodc.org/pdf/india/presentations/india_national_survey_2004.pdf (2004, accessed 20 March 2019).

Ambekar

and Goyal

. Clinical practice guidelines (CPG) for the management of opioid use disorders , http://www.indianjpsychiatry.org/documents/IPSCPGSUDSynopsisBook2015.pdf (accessed 24 January 2019).

International Narcotics Control Board. Treatment, rehabilitation and social reintegration for drug use disorders: Essential components of drug demand reduction. In: Report of the International Narcotics Control Board for 2017 . Vienna: United Nations Office, 2018. pp. 1–15. http://www.incb.org/documents/Publications/AnnualReports/AR2019/Annual_Report/English_ebook_AR2019.pdf (accessed 15 January 2019).

Kumar

, Samson

, Momenghalibaf

et al. Advocacy brief: Pharmaceutical injection drug use in South Asia . New Delhi: Indian Harm Reduction Network, Response Beyond Borders and Sharan, http://naco.gov.in/sites/default/files/Opiod%20Substitution%20Therapy%20Guideline.pdf (accessed 15 January 2019).

Westermeyer

, Crosby

and Nugent

. The Minnesota substance abuse problems scale. Psychometric analysis and validation in a clinical population. Am J Addict 1998; 7(1): 24–34.

Reyes

ADL

, Makol

, Racz

et al. The work and social adjustment scale for youth: A measure for assessing youth psychosocial impairment regardless of mental health status. J Child Fam Stud 2019; 28(1): 1–16. doi:10.1007/s10826-018-1238-6.

Lovibond

, Lovibond

. Manual for the depression anxiety and stress scales . 2nd ed. Sydney: Psychology Foundation. https://maic.qld.gov.au/wp-content/uploads/2016/07/DASS-21.pdf (1995, accessed 4 September 2022).

Vahedi

World Health Organization Quality-of-Life Scale (WHOQOL-BREF): Analyses of their item response theory properties based on the graded responses model. Iran J Psychiatry 2010; 5: 140–153.

10.

Khanna

42 per cent addicts in UT inject drugs: PGI study. The Tribune , https://www.tribuneindia.com/news/archive/chandigarh/news-detail-464858 (10 September 2017, accessed 4 September 2022).

11.

Degenhardt

, Peacock

, Colledge

et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: A multistage systematic review. Lancet Glob Health 2017; 5(12): e1192–e1207. https://pubmed.ncbi.nlm.nih.gov/29074409/

12.

Solomon

, Desai

, Srikrishnan

et al. The profile of injection drug users in Chennai, India: Identification of risk behaviours and implications for interventions. Substance Use Misuse 2010; 45(3): 354–367. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924430/

13.

Panda

and Kumar

. Injecting drug use in India and the need for policy and program change. Int J Drug Policy 2016; 37: 115–116.

14.

, Hershow

, Irwanto

et al. Factors associated with symptoms of depression among injection drug users receiving antiretroviral treatment in Indonesia. J AIDS Clin Res 2014; 5(5): 303.

15.

Mawiong

, Senjam

, Haobam

et al. A study of psychiatric comorbidities among treatment seeking opioid injectors attending tertiary care teaching hospital, Imphal for a period of 2 years. J Med Soc 2018; 32(3): 174–177.

16.

Taí de Campos

, Figueiró

, Fernandes

et al. Quality of life of users of psychoactive substances, relatives, and non-users assessed using the WHOQOL-BREF. Ciên Saúde Colet 2013; 18(7): 1953–1962.

17.

Daley

DC.

Family and social aspects of substance use disorders and treatment. J Food Drug Anal 2013; 21(4): S73–S76.